TI Health Is Now Part of Swoop: Unify Your HCP and DTC Marketing

The integration elevates Swoop’s ability to reach, target and engage HCPs, enabling a better solution for healthcare marketers.

Swoop is proud to announce the integration of TI Health, a data-driven marketing and predictive analytics company that delivers omnichannel health care provider (HCP) engagement insights and activation solutions, into its already robust offering. By acquiring TI Health, Swoop – the leading provider of exclusive privacy-safe patient audiences – now offers a fully unified HCP and direct-to-consumer (DTC) system of engagement for healthcare marketers. 

 “Historically, HCP and DTC advertising have functioned independently, engaging physicians and patients separately despite a common objective of increasing awareness of new therapies designed to improve health,” said Scott Rines, President, Swoop. “This has led to wasted budgets, unoptimized activation and suboptimal script lift. By combining TI Health’s best-in-class HCP targeting and activation with Swoop’s highly precise patient audiences, brands are now able to coordinate engagement with their ideal patient and HCP audiences, driving greater Rx lift and delivering sustained benefits to patients.”

 As part of the integration, Swoop is launching four new solutions that connect its system of engagement with the TI Health Affiniti^TM insights platform. These offerings leverage content, message and channel affinity data for more than 1.6 million HCPs, drawing on more than 500 million observed NPI exposures and engagements.

-       HCP Programmatic Activation: DSP-agnostic, this is the only self-serve HCP programmatic solution with physician level detail (PLD) reporting. Marketers can engage HCPs based on individual media preferences and incorporate time-sensitive triggers using diagnosis, affiliation, payer and prescribing behavior.

-       HCP Social Media Engagement: Marketers can apply the same ideal HCP audience used for programmatic advertising to self-serve on social media, engaging verified HCPs, including key opinion leaders and influencers, on the most popular networks such as Facebook, Twitter, Instagram and TikTok.

-       HCP TV Planning and Activation: The first HCP TV advertising solution scaled across addressable TV (ATV) and connected TV (CTV)/over-the-top (OTT) to reach verified NPI households. Advertisers can apply the same audience used in digital channels for TV planning and activation to optimize reach and frequency.

-       HCP Targeting with Hospital/IDN Affiliation and Payer Data: Provider-based targeting and top decile targeting of HCPs seeing patients with specific payer coverage delivers further audience refinement beyond diagnosis and prescribing behavior. 

“Reaching HCPs has become harder than ever with the decline of face-to-face engagement and the oversaturation of non-personal promotion,” said TI Health Founder and CEO, Erin DeRuggiero. “Personalized omnichannel for HCPs, based on their affinity for specific content, messaging and channels, allows healthcare marketers to break through the noise in the moments that matter and meet HCPs where they are, establishing their brand as the therapy of choice. Joining Swoop allows us to accelerate the innovation and scale of our AI powered audience expansion and activation capabilities. When HCP and DTC engagement works in tandem, in clinical, endemic and non-endemic environments, advertisers, healthcare professionals and patients will all benefit.”

To learn more about how Swoop can help engage more than 1.6M HCPs in their preferred channel with the best message on the ideal device, including at 50,000+ point of care locations, click here.

###

ABOUT TI HEALTH

TI Health is a data driven marketing and predictive analytics company, delivering omni-channel insights and activation solutions for healthcare companies and pharmaceutical brands. TI Health's proprietary predictive analytics platform Affiniti™ to map content, messaging, and channel strategy preferences for leading pharmaceutical brand marketers in the United States.

ABOUT SWOOP

Swoop, part of Real Chemistry, empowers the world’s leading pharmaceutical brands to better educate patients about disease states and the therapies that could remedy their conditions, as well as enable them to become active participants in their treatment journey. Swoop’s HIPAA-certified and NAI-accredited system of engagement has uncovered over 6,000 unique target audiences for precisely activating patient populations and their healthcare ecosystems through omnichannel marketing strategies. By utilizing artificial intelligence in conjunction with a real world data universe of over 300 million de-identified patient journeys over ten years, Swoop’s segments are superior in audience quality, lead to optimal conversion and drive increased Rx lift, which is why 18 of the top 20 healthcare marketing agencies and 42 of the top 50 pharmaceutical companies power their marketing efforts with Swoop.